Ja. Price et al., EFFECTS OF THE ADJUVANT MPL+TDM ON TUMOR CHALLENGE IN THE B16 MOUSE MELANOMA MODEL, International journal of immunopharmacology, 18(2), 1996, pp. 163-165
Mice were injected three times at 2 week intervals with the adjuvant M
PL+TDM or phosphate-buffered saline. Two weeks after the last injectio
n, all mice were challenged subcutaneously with a tumorgenic dose of B
l6 tumor and observed for 40 days. The adjuvant hastened the time at w
hich tumors appeared (P = 0.02). Copyright (C) 1996 International Soci
ety for Immunopharmacology